Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Schut

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatinBastiaan Evers, Rinske Drost, Eva Schut, et al.
Cancer Research|August 18, 2018
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547Sjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
Nature Genetics|June 27, 2017
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinomaSjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
Genes & Development|June 25, 2016
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary glandStefano Annunziato, Sjors M Kas, Micha Nethe, et al.
Nature|August 2, 2019
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisMax D Wellenstein, Seth B Coffelt, Danique E M Duits, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Nature|August 10, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatinBastiaan Evers, Rinske Drost, Eva Schut, et al.
Cancer Research|August 18, 2018
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547Sjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
Nature Genetics|June 27, 2017
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinomaSjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
Genes & Development|June 25, 2016
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary glandStefano Annunziato, Sjors M Kas, Micha Nethe, et al.
Nature|August 2, 2019
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisMax D Wellenstein, Seth B Coffelt, Danique E M Duits, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Nature|August 10, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
Pageof 2